The companies said in separate filings that they had each received requests for additional information on Sept. 2, the day the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act was expected to expire. Once Express Scripts and Medco comply with the requests, the waiting period will be extended by 30 days.
“Express Scripts and Medco intend to respond to the second request as promptly as practicable,” according to a statement that appeared in both filings. “While the companies cannot specify how long it will take to comply with the second request, they continue to anticipate the transactions contemplated by the merger agreement will close in the first half of 2012, as previously announced.”
Pharmacy trade groups have publicly opposed the merger, stating that the combined company will be anti-competitive and could have negative effects on patients.